The only pathway that was significantly downregulated in COVID-19 monocytes was glycolysis (Fig. 3a and Dataset 5), with decreased expression of a number of enzymes involved in glucose degradation, including PFKP, ENO1, PFKB4 and others (Fig. 3b). The gene discussed is ENO1; the disease is COVID-19.